HIGHLIGHTS
- who: Hospitalizations Away? et al. from the Medical College, Chinakakani, IND Medicine, California Institute of Neurosciences and Psychology have published the research work: Received 08/22/2022 Review began 02/28/2023 Review ended 04/05/2023 Published 04/09/2023, in the Journal: (JOURNAL) of April/09,/2023
- what: In this review article, the authors focused on different papers to address the benefits of adding sacubitril/valsartan in reducing hospitalizations, hospital readmissions, and adverse effects, along with comparing the cost-benefit of the drug and prescribing optimal doses.
- how: Intending to improve . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.